MDXHEALTH SA
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $107.9M | $90.0M | $70.2M | $37.1M | $22.2M | $18.5M | $11.8M |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | $-14.4M | $-24.7M | $-27.3M | $-37.9M | $-26.8M | $-27.1M | $-43.2M |
| Operating Margin | -13.4% | -27.5% | -38.9% | -102.3% | -120.7% | -146.9% | -366.3% |
| Interest Expense | $786.0K | $384.0K | $355.0K | $314.0K | $229.0K | $89.0K | — |
| Pretax Income | $-35.4M | $-37.7M | $-43.1M | $-44.0M | $-29.0M | $-28.7M | $-43.7M |
| Income Tax Expense | $-1.9M | $382.0K | $1.0K | $0 | $0 | $0 | $-575.0K |
| Net Income | $-33.5M | $-38.1M | $-43.1M | $-44.0M | $-29.0M | $-28.7M | $-43.1M |
| Net Margin | -31.1% | -42.3% | -61.4% | -118.9% | -130.4% | -155.3% | -365.7% |
| EPS (Basic) | $-0.67 | $-1.16 | $-1.66 | $-2.78 | $-2.38 | $-0.34 | $-0.69 |
| EPS (Diluted) | $-0.67 | $-1.16 | $-1.66 | $-2.78 | $2.38 | $0.34 | $-0.69 |
| Shares Outstanding (Basic) | 51.4M | 49.5M | 27.3M | 0 | 156.0M | — | — |
| Shares Outstanding (Diluted) | 51.4M | 49.5M | 27.3M | 0 | 156.0M | — | — |
| Dividends Per Share | — | — | — | — | — | — | — |